FURIN regulates cytotoxic T‐lymphocyte effector function and memory cell transition in mice

The proprotein convertase subtilisin/kexins (PCSKs) regulate biological actions by cleaving immature substrate proteins. The archetype PCSK, FURIN, promotes the pathogenicity of viruses by proteolytically processing viral proteins. FURIN has also important regulatory functions in both innate and adaptive immune responses but its role in the CD8+ CTLs remains enigmatic. We used a T‐cell‐specific FURIN deletion in vivo to demonstrate that FURIN promotes host response against the CTL‐dependent lymphocytic choriomeningitis virus by virtue of restricting viral burden and augmenting interferon gamma (IFNG) production. We also characterized Furin KO CD8+ T cells ex vivo, including after their activation with FURIN regulating cytokines IL12 or TGFB1. Furin KO CD8+ T cells show an inherently activated phenotype characterized by the upregulation of effector genes and increased frequencies of CD44+, TNF+, and IFNG+ cells. In the activated CTLs, FURIN regulates the productions of IL2, TNF, and GZMB and the genes associated with the TGFBR‐signaling pathway. FURIN also controls the expression of Eomes, Foxo1, and Bcl6 and the levels of ITGAE and CD62L, which implies a role in the development of CTL memory. Collectively, our data suggest that the T‐cell expressed FURIN is important for host responses in viral infections, CTL homeostasis/activation, and memory development.

[1]  Amit A. Patel,et al.  Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) , 2021, European journal of immunology.

[2]  Z. Ortutay,et al.  Identification of Novel Genetic Regulatory Region for Proprotein Convertase FURIN and Interferon Gamma in T Cells , 2021, Frontiers in Immunology.

[3]  Vineet D. Menachery,et al.  Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis , 2021, Nature.

[4]  B. Monk,et al.  Gemogenovatucel-T (Vigil) immunotherapy as maintenance in frontline stage III/IV ovarian cancer (VITAL): a randomised, double-blind, placebo-controlled, phase 2b trial. , 2020, The Lancet. Oncology.

[5]  W. Xu,et al.  The role of furin cleavage site in SARS-CoV-2 spike protein-mediated membrane fusion in the presence or absence of trypsin , 2020, Signal Transduction and Targeted Therapy.

[6]  Pei-Jer Chen,et al.  Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic Effects , 2020, Cell Reports.

[7]  J. Creemers,et al.  Loss of the proprotein convertase Furin in T cells represses mammary tumorigenesis in oncogene-driven triple negative breast cancer. , 2020, Cancer letters.

[8]  A. Khatib,et al.  Proprotein convertases: Key players in inflammation-related malignancies and metastasis , 2019, Cancer Letters.

[9]  I. Soubeyran,et al.  Inactivation of proprotein convertases in T cells inhibits PD-1 expression and creates a favorable immune microenvironment in colorectal cancer. , 2019, Cancer research.

[10]  D. Sauter,et al.  Furin‐mediated protein processing in infectious diseases and cancer , 2019, Clinical & translational immunology.

[11]  E. Tartour,et al.  Editorial: Tissue Resident Memory T Cells , 2019, Front. Immunol..

[12]  O. Silvennoinen,et al.  Increased expression of the proprotein convertase enzyme FURIN in rheumatoid arthritis , 2018, Scandinavian journal of rheumatology.

[13]  M. Najafi,et al.  CD8+ cytotoxic T lymphocytes in cancer immunotherapy: A review , 2018, Journal of cellular physiology.

[14]  F. Mami-Chouaib,et al.  The Emerging Role of CD8+ Tissue Resident Memory T (TRM) Cells in Antitumor Immunity: A Unique Functional Contribution of the CD103 Integrin , 2018, Front. Immunol..

[15]  O. Silvennoinen,et al.  Proprotein convertase enzyme FURIN is upregulated in primary Sjögren's syndrome. , 2018, Clinical and experimental rheumatology.

[16]  M. Rämet,et al.  Proprotein convertase Furin1 expression in the Drosophila fat body is essential for a normal antimicrobial peptide response and bacterial host defense , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  Reinhold Förster,et al.  Mechanisms and Dynamics of T Cell-Mediated Cytotoxicity In Vivo. , 2017, Trends in immunology.

[18]  I. Frazer,et al.  Interferon-γ derived from cytotoxic lymphocytes directly enhances their motility and cytotoxicity , 2017, Cell Death & Disease.

[19]  T. Järvinen,et al.  T-cell-expressed proprotein convertase FURIN inhibits DMBA/TPA-induced skin cancer development , 2016, Oncoimmunology.

[20]  M. Nykter,et al.  Myeloid cell expressed proprotein convertase FURIN attenuates inflammation , 2016, Oncotarget.

[21]  Nu Zhang,et al.  Transforming growth factor-β signaling is constantly shaping memory T-cell population , 2015, Proceedings of the National Academy of Sciences.

[22]  C. Ortutay,et al.  Proprotein convertase FURIN regulates T cell receptor‐induced transactivation , 2015, Journal of leukocyte biology.

[23]  N. Senzer,et al.  Pilot Trial of FANG Immunotherapy in Ewing's Sarcoma , 2015, Molecular therapy : the journal of the American Society of Gene Therapy.

[24]  William Ritchie,et al.  Real-time tracking of cell cycle progression during CD8+ effector and memory T-cell differentiation , 2015, Nature Communications.

[25]  G. Corthals,et al.  Proprotein Convertase FURIN Constrains Th2 Differentiation and Is Critical for Host Resistance against Toxoplasma gondii , 2014, The Journal of Immunology.

[26]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[27]  D. Bluteau,et al.  Smad and NFAT Pathways Cooperate To Induce CD103 Expression in Human CD8 T Lymphocytes , 2014, The Journal of Immunology.

[28]  Z. Ortutay,et al.  Genetics of the First Seven Proprotein Convertase Enzymes in Health and Disease , 2013, Current genomics.

[29]  J. Schlom,et al.  Inhibition of TGF-β1 Signaling Promotes Central Memory T Cell Differentiation , 2013, The Journal of Immunology.

[30]  M. Huber,et al.  The transcription factor Interferon Regulatory Factor 4 is required for the generation of protective effector CD8+ T cells , 2013, Proceedings of the National Academy of Sciences.

[31]  Wei Shi,et al.  featureCounts: an efficient general purpose program for assigning sequence reads to genomic features , 2013, Bioinform..

[32]  Susan M. Kaech,et al.  Transcriptional control of effector and memory CD8+ T cell differentiation , 2012, Nature Reviews Immunology.

[33]  Annik Prat,et al.  The biology and therapeutic targeting of the proprotein convertases , 2012, Nature Reviews Drug Discovery.

[34]  D. Rao,et al.  Phase I Trial of "bi-shRNAifurin/GMCSF DNA/Autologous Tumor Cell" Vaccine (FANG) in Advanced Cancer. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

[35]  S. Brunak,et al.  A Systematic Study of Site-specific GalNAc-type O-Glycosylation Modulating Proprotein Convertase Processing* , 2011, The Journal of Biological Chemistry.

[36]  Helga Thorvaldsdóttir,et al.  Integrative Genomics Viewer , 2011, Nature Biotechnology.

[37]  E. Birney,et al.  Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt , 2009, Nature Protocols.

[38]  Chunxia Chen,et al.  Foxp3 Processing by Proprotein Convertases and Control of Regulatory T Cell Function* , 2009, Journal of Biological Chemistry.

[39]  Israel Steinfeld,et al.  BMC Bioinformatics BioMed Central , 2008 .

[40]  Y. Belkaid,et al.  T-cell-expressed proprotein convertase furin is essential for maintenance of peripheral immune tolerance , 2008, Nature.

[41]  Douglas C. Wilson,et al.  IL-12 Signaling Drives CD8+ T Cell IFN-γ Production and Differentiation of KLRG1+ Effector Subpopulations during Toxoplasma gondii Infection1 , 2008, The Journal of Immunology.

[42]  J. O’Shea,et al.  Proprotein convertase furin is preferentially expressed in T helper 1 cells and regulates interferon gamma. , 2006, Blood.

[43]  A. Lauwers,et al.  Limited Redundancy of the Proprotein Convertase Furin in Mouse Liver* , 2004, Journal of Biological Chemistry.

[44]  R. Lahesmaa,et al.  Early Target Genes of IL-12 and STAT4 Signaling in Th Cells1 , 2004, The Journal of Immunology.

[45]  S. Szabo,et al.  Antigen-driven effector CD8 T cell function regulated by T-bet , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[46]  N. Miyasaka,et al.  SOCS-3 inhibits IL-12-induced STAT4 activation by binding through its SH2 domain to the STAT4 docking site in the IL-12 receptor beta2 subunit. , 2003, Biochemical and biophysical research communications.

[47]  G. Thomas,et al.  Furin at the cutting edge: From protein traffic to embryogenesis and disease , 2002, Nature Reviews Molecular Cell Biology.

[48]  Laurie H Glimcher,et al.  A Novel Transcription Factor, T-bet, Directs Th1 Lineage Commitment , 2000, Cell.

[49]  R. Ahmed,et al.  CD4+ and CD8+ T cell interactions in IFN-gamma and IL-4 responses to viral infections: requirements for IL-2. , 1998, Journal of immunology.

[50]  M. Bevan,et al.  Massive expansion of antigen-specific CD8+ T cells during an acute virus infection. , 1998, Immunity.

[51]  J. Orange,et al.  Mechanism of interleukin 12-mediated toxicities during experimental viral infections: role of tumor necrosis factor and glucocorticoids , 1995, The Journal of experimental medicine.

[52]  J. Orange,et al.  Effects of IL-12 on the response and susceptibility to experimental viral infections. , 1994, Journal of immunology.

[53]  J. Thorner,et al.  Intracellular targeting and structural conservation of a prohormone-processing endoprotease. , 1989, Science.

[54]  Sven Rahmann,et al.  Genome analysis , 2022 .

[55]  Nikolaj Blom,et al.  Prediction of proprotein convertase cleavage sites. , 2004, Protein engineering, design & selection : PEDS.

[56]  N. Seidah,et al.  Evidence that furin is an authentic transforming growth factor-beta1-converting enzyme. , 2001, The American journal of pathology.

[57]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .